Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,016 public trials 2,558 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

NCT07209449

Conditions
Disease Attributes, Endometrial Cancer, Endometrial Neoplasms, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Recruiting

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

NCT05918263

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Recruiting

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

NCT07286266

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Hyōgo, Japan
View Trial Details
Recruiting

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

NCT07278336

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Sarah Cannon Research Institute at HealthONE /ID# 278785 Denver, Colorado, United States
  • University of Chicago Medical Center /ID# 278295 Chicago, Illinois, United States
  • NEXT Oncology - San Antonio /ID# 278606 San Antonio, Texas, United States
  • Start Mountain Region /ID# 278609 West Valley City, Utah, United States
View all 17 locations
View Trial Details
Recruiting

The TASTY-steering Study

NCT07258563

Conditions
Breast Diseases, Breast Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Amsterdam UMC Amsterdam, Netherlands
  • Rijnstate Ziekenhuis Arnhem, Netherlands
  • Van Weel-Bethesda Ziekenhuis Dirksland, Netherlands
  • Ziekenhuisvoorzieningen Gelderse Vallei Ede, Netherlands
View Trial Details

Related conditions